Skip to main navigation Skip to search Skip to main content

Benign fibrous dysplasia on [11C]choline PET: A potential mimicker of disease in patients with biochemical recurrence of prostate cancer

  • Chris N. Gu
  • , Christopher H. Hunt
  • , Vance T. Lehman
  • , Geoffrey B. Johnson
  • , Felix E. Diehn
  • , Kara M. Schwartz
  • , Laurence J. Eckel

Research output: Contribution to journalArticlepeer-review

Abstract

We present the case of a 74-year-old male with biochemical recurrence of prostate cancer who underwent [11C]choline PET/CT. The PET/CT demonstrated an intense focus of uptake within the skull base that was initially felt to potentially represent metastatic disease. Subsequent evaluation with MRI and dedicated thin-section CT revealed this area to be benign fibrous dysplasia of the bone. The focal uptake on PET/CT with [11C]choline in benign fibrous dysplasia represents a potential mimicker of metastatic disease. Due to recognizing this benign process, our patient was able to avoid systemic treatment and/or focal radiation and was treated with cryotherapy for biopsy-proven local recurrence within the prostate bed. While benign fibrous dysplasia can demonstrate increased radiotracer uptake on other modalities (i.e., bone scintigraphy, FDG PET/CT), its appearance on [11C]choline PET/ CT has been largely overlooked in the literature. With the increasing use of [11C]choline PET/CT for biochemical recurrent prostate cancer evaluation, it is important to understand this potential mimicker of disease.

Original languageEnglish (US)
Pages (from-to)599-602
Number of pages4
JournalAnnals of Nuclear Medicine
Volume26
Issue number7
DOIs
StatePublished - Aug 2012

Keywords

  • Fibrous dysplasia
  • PET/CT
  • Prostate cancer
  • [C]choline

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Benign fibrous dysplasia on [11C]choline PET: A potential mimicker of disease in patients with biochemical recurrence of prostate cancer'. Together they form a unique fingerprint.

Cite this